Skip main navigation
International Stroke Conference 2019 Oral Abstracts
Session Title: Acute Endovascular Treatment Oral Abstracts I

Abstract 4: Endovascular Thrombectomy May Be Safe and Effective in Patients With Large Core Lesions on Either Simple CT or Perfusion Images

Originally published 2019;50:A4

    Background: Endovascular thrombectomy (EVT) efficacy and safety is not established in patients with large core. We evaluated the clinical and radiologic outcomes following EVT in acute strokes with large ischemic core lesions defined by CT ASPECTS and/or CTP.

    Methods: From a multicenter prospective cohort study of imaging selection for thrombectomy (SELECT), patients with large ischemic core on CTP (rCBF< 30%) >50 ml and/or ASPECT≤5 up to 24 hrs from last known well were identified at 9 U.S centers. All patients received a baseline CT and CTP with automated ischemic core determination by RAPID. A blinded core lab adjudicated all images. The primary outcome was 90 day mRS 0-2. Safety outcomes were sICH and mortality. Outcomes of EVT patients were compared to those who received medical management (MM) only.

    Results: Of 445 enrolled, 106 had large core on either CT or CTP: 71 ASPECTS≤5 (EVT 37, MM 34) and 75 CTP core >50 ml (EVT 40, MM 35), 40 on both CT and CTP. Median (IQR) age 66 yr, NIHSS 20 (16-23), time to puncture 224 min (range 69-832), ASPECTS 5 (4-6) and CTP core 72 ml (41-96). Baseline characteristics were similar in EVT vs. MM patients in both CT and CTP definition groups. The EVT group had better mRS 0-2 rates as compared to MM (32 % vs 14%), aOR: 2.9 (95% CI: 1.0-7.9, p=0.041) and a favorable mRS shift on ordinal analysis aOR: 2.0 (95% CI 1.0-4.1, p=0.049), smaller final infarct volume 96 (49-196) vs 175 (127-225) ml, p=0.02, and less infarct growth 44 (0.7-107.6) vs 83 (61-133) ml, p=0.03 with similar mortality 29% EVT, 42% MM, p=0.16 and sICH 13% EVT, 7% MM, p=0.3. EVT patients were more likely to achieve mRS 0-2 if treated early (0-6) vs late (>6-24 hrs) for both CTP defined (27% vs 0%) and CT defined large core (44% vs. 18%). The good outcome declined by 20% for each hr of treatment delay (Fig 1).

    Conclusion: EVT may be effective and safe for patients with a large core, especially if treated early. RCTs are needed.


    Author Disclosures: A. Sarraj: Research Grant; Modest; Principal Investigator of the SELECT and SELECT 2 trials with unrestricted grant from Stryker Neurovascular. Research Grant; Significant; Significant. Other Research Support; Modest; site PI for DEFUSE 3 trial funded by the National Institutes of Health. Other Research Support; Significant; Modest. Speakers' Bureau; Modest; Speaker bureau for Stryker Neurovascular. Speakers' Bureau; Significant; Significant. Consultant/Advisory Board; Modest; Consultant and advisory board for Stryker Neurovascular. Consultant/Advisory Board; Significant; Significant. A. Hassan: None. J. Grotta: Research Grant; Modest; Genentech--tPA for research study. Consultant/Advisory Board; Modest; Frazer Ltd. C. Sitton: None. P. Chen: None. N. Vora: None. C. Cai: None. G. Cutter: None. D. Pujara: None. B. Imam: None. S. Reddy: None. H. Kamal: None. M. Abraham: None. L. McCullough: None. M. Lansberg: None. S. Savitz: None. R. Gupta: None. G. Albers: None.


    eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

    Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.